SUPPRESSION OF CANCER
The present invention relates to polypeptides for use in suppressing cancer and cancer disorders. The treatment employs use of a non-cytotoxic protease, which is targeted to the cancer cell, and, when so delivered, the protease is internalised and inhibits secretion from the cancer cell. L'inve...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French |
Published |
08.01.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to polypeptides for use in suppressing cancer and cancer disorders. The treatment employs use of a non-cytotoxic protease, which is targeted to the cancer cell, and, when so delivered, the protease is internalised and inhibits secretion from the cancer cell.
L'invention porte sur des polypeptides destinés à être utilisés pour supprimer des cancers et des affections cancéreuses. Le traitement utilise une protéase non cytotoxique qui est ciblée sur la cellule cancéreuse et qui, une fois administrée, est internalisée et inhibe la sécrétion par la cellule cancéreuse. |
---|---|
AbstractList | The present invention relates to polypeptides for use in suppressing cancer and cancer disorders. The treatment employs use of a non-cytotoxic protease, which is targeted to the cancer cell, and, when so delivered, the protease is internalised and inhibits secretion from the cancer cell.
L'invention porte sur des polypeptides destinés à être utilisés pour supprimer des cancers et des affections cancéreuses. Le traitement utilise une protéase non cytotoxique qui est ciblée sur la cellule cancéreuse et qui, une fois administrée, est internalisée et inhibe la sécrétion par la cellule cancéreuse. |
Author | MADEC, FREDERIC LECANE, PHILIP MARKS, PHILIP FOSTER, KEITH |
Author_xml | – fullname: MARKS, PHILIP – fullname: LECANE, PHILIP – fullname: FOSTER, KEITH – fullname: MADEC, FREDERIC |
BookMark | eNrjYmDJy89L5WQQDQ4NCAhyDQ729PdT8HdTcHb0c3YN4mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORuYmhpZGls7GhFUAAOiZH9A |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | SUPPRESSION DE CANCERS |
ExternalDocumentID | CA2741929C |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA2741929C3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:30:13 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA2741929C3 |
Notes | Application Number: CA20092741929 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190108&DB=EPODOC&CC=CA&NR=2741929C |
ParticipantIDs | epo_espacenet_CA2741929C |
PublicationCentury | 2000 |
PublicationDate | 20190108 |
PublicationDateYYYYMMDD | 2019-01-08 |
PublicationDate_xml | – month: 01 year: 2019 text: 20190108 day: 08 |
PublicationDecade | 2010 |
PublicationYear | 2019 |
RelatedCompanies | SYNTAXIN LIMITED |
RelatedCompanies_xml | – name: SYNTAXIN LIMITED |
Score | 3.181326 |
Snippet | The present invention relates to polypeptides for use in suppressing cancer and cancer disorders. The treatment employs use of a non-cytotoxic protease, which... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
Title | SUPPRESSION OF CANCER |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190108&DB=EPODOC&locale=&CC=CA&NR=2741929C |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1La8JAEB7UFttbaxX7zqHkFhrduEkPoegmQQqaYLV4k4zZYC9Wakr_fmeXpO3F27ILw87APL7ZnRmAh76XMsRMWtjvIQEUJ7OQDdBCyVwvZ1w6uQKKkykfL5yX5WBZg01VC6P7hH7r5oikUWvS90Lb691fEivQfyv3j_hOWx_P0dwPzBIdK-9me2Yw8sMkDmJhCuGLoTmd-apLC0UCog5HFES7ShfCt5GqSdn9dyjRGRwnRGtbnENNbltwIqq5ay1oTsrnblqWmre_gPbrItHSIttnxJEh1FCZWRvuo3AuxhbRX_2yshLD6iKsAw0C-LILhmrGSQCXr1OX4hm00_yJI7czziRFH8guoXuIytXho2s4VQLR6QLvBhrF55e8JQda4J3m_Qc6yHJF |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDLbGQIwbjKHxXA-ot4qydG05VGhLWxVYHxod2q1q1lTjMiZWxN_HiVrgsluUSFZiyfb3JbENcDu0c8JYwTU2vGdIUIxCY2TENMaJZZfE5EYpiGIYmcHceF6MFi1YNbkwsk7otyyOiBa1RHuvpL_e_F1iufJv5faOvePUx6OfOq5as2MR3XRbdSeOl8RuTFVKHTpWo5kjqrQgEqB7sI8A2xK24L1NRE7K5n9A8Y_hIEFZ6-oEWnzdhQ5t-q514TCsn7txWFve9hR6r_NEagt9nxL7ChVNZWY9GPheSgMN5We_R8nouNkIOYM2EnzeB0UU40SCay5zC_EM0_PywWSmXpiEI_pg5Bz6u6Rc7F4aQCdIw2k2fYpeLuFIKEdeHdhX0K4-v_g1BtOK3Ug9_ADAfXU4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SUPPRESSION+OF+CANCER&rft.inventor=MARKS%2C+PHILIP&rft.inventor=LECANE%2C+PHILIP&rft.inventor=FOSTER%2C+KEITH&rft.inventor=MADEC%2C+FREDERIC&rft.date=2019-01-08&rft.externalDBID=C&rft.externalDocID=CA2741929C |